Dar Al Dawa Development and Investment Co. Ltd. (ASE: DADI)

Market Cap	43.75M
Revenue (ttm)	77.56M
Net Income (ttm)	3.10M
Shares Out	35.00M
EPS (ttm)	0.09
PE Ratio	14.16
Forward PE	n/a
Dividend	0.05 (3.97%)
Ex-Dividend Date	n/a

Volume	8,062
Open	1.230
Previous Close	1.250
Day's Range	1.220 - 1.260
52-Week Range	1.180 - 1.420
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, produces, markets, and commercializes medicines and wellness consumer products. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, nervous system, gastrointestinal, dermatology, eye-ear preparations, genitourinary system and sex hormones, analgesic, respiratory system, and vitamins and natural products. It serves patients in approximately 40 countries throughout the Middle East, North Africa, and Eur...

• Industry: Pharmaceutical Preparations
• Founded: 1975
• Employees: 1,067
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: DADI

Financial Performance

In 2023, DADI's revenue was 74.88 million, an increase of 24.06% compared to the previous year's 60.36 million. Earnings were 3.16 million, an increase of 59.21%.